# MannKind reaches manufacturing milestone with $60M expansion for Tyvaso DPI

MannKind Corporation has scaled-up operations for increased production capacity of Tyvaso DPI, representing a $60 million investment. Construction is ongoing to build out new manufacturing space in Danbury, Connecticut.

- Type: Expansion
- Announced: 2023-06-11
- Where: Danbury, Connecticut, United States
- Value: $60.0M
- Status: under construction
- Products: Tyvaso DPI, dry-powder formulations, inhalation devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MannKind Corporation](https://endata.com/companies/62910.md)
- [United Therapeutics](https://endata.com/companies/70770.md) (partner)

## Sources

- [biospace.com](https://www.biospace.com/governor-ned-lamont-to-tour-mannkind-june-12-as-it-reaches-a-manufacturing-milestone), 2023-06-11: "Through MannKind’s partnership with United Therapeutics the current expansion project represents a $60 million investment."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.